The global ophthalmic therapeutics/drugs market size is expected to value at USD 35.7 billion by 2025 at CAGR of 5.1% in forecast period, providing numerous opportunity for market players to invest for research and development in the market.
Ophthalmic Therapeutics/Drugs Market Revenue Drivers, Growth
Opportunities, Supply Chain Analysis and Forecast Research Report Till
2025
The global Ophthalmic Therapeutics/Drugs Market research report provides complete insights on industry
scope, trends, regional estimates, key application, competitive landscape and financial performance of
prominent players. It also offers ready data-driven answers to several industry-level questions. This study
enables numerous opportunities for the market players to invest in research and development.
Market Overview:
The global ophthalmic therapeutics/drugs market size is expected to value at USD 35.7 billion by 2025.
The market is subject to witness a substantial growth due to the rising occurrence of eye diseases like
presbyopia, macular degeneration, and retinal vascular disease, particularly in geriatric population.
Key Players:
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
“The global ophthalmic therapeutics/drugs market size is
expected to value at USD 35.7 billion by 2025 at CAGR of
5.1% in forecast period, providing numerous opportunity
for market players to invest for research and development
in the market.”
Request free sample to get complete analysis of top-performing companies @
https://www.millioninsights.com/industry-reports/ophthalmic-therapeutics-drugs-market/request-
sample
Growth Drivers:
Increasing focus on research and development in ophthalmic therapeutics and drugs by private bodies
due to rising occurrence of ocular disorders, are driving factors for growth of the market. Globally, the
ophthalmic therapeutics/drugs industry is predicted to grow at CAGR of 5.1% in forecast period,
providing numerous opportunity for market players to invest for research and development in the
market.
Drug Class Outlook
Ant